Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06481436 · ClinicalTrials.gov registry record · NA
Use of Artificial Intelligence by Urogynecologic Patients
A NA study of Urinary Incontinence and Lower Urinary Tract Symptoms, sponsored by Hartford Hospital.
- Active
- Registry status
- NA
- Development phase
- 125
- Enrollment target
- 1
- Study location
NCT06481436: Active NA study of Urinary Incontinence and Lower Urinary Tract Symptoms, sponsored by Hartford Hospital.
NCT06481436 is a NA study of Urinary Incontinence and Lower Urinary Tract Symptoms that is active but no longer recruiting, run by Hartford Hospital. The registered enrollment target is 125 participants, below the 259-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (52% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06481436, a NA study of Urinary Incontinence and Lower Urinary Tract Symptoms, is active but no longer recruiting, sponsored by Hartford Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 125 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn about how Urogynecology patients use Artificial Intelligence (AI) Chatbots like ChatGPT, and how it affects healthcare decision making. The main question\[s\] it aims to answer are: * How does the AI Chatbot affect participants' understanding of diagnoses and participant satisfaction with a urogynecology consultation? * How accurate is the chatbot-provided diagnosis and counseling information? Participants will be asked to use the ChatGPT chatbot and ask it questions about the main problem the participant is seeing the doctor for, and will also be asked to fill out some questionnaires. Researchers will compare using the Chatbot before the visit, after the visit, or not at all to see if the way participants understand the information changes based on timing of use.
Primary Outcome
The effect of use of an AI Chatbot platform on participant understanding of diagnosis at the initial urogynecology visit. This will be measured by the incidence of agreement of participant-reported diagnosis with their physician-reported diagnosis. The physician will be asked the patient's primary diagnosis in one multiple choice question (part of Physician Questionnaire). There are no minimum or maximum values to this questionnaire, and there are no answers that would mean a better or worse out
Conditions Studied
Interventions
- BEHAVIORAL Use of ChatGPT
Study Locations (1)
Connecticut
- Hartford Hospital - Hartford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2024-07-22 |
| Est. Completion | 2025-04-01 |
| Phase | NA |
What the registry record for NCT06481436 still lists
NCT06481436 is an interventional study that assigns participants to a tested intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap, below the 259-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (52% lower).
The record links to 3 conditions, with Urinary Incontinence appearing as the primary indexed condition, and to 1 intervention - of which Use of ChatGPT is the first listed.
NCT06481436 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT06481436 about?
NCT06481436 is a clinical study titled "Use of Artificial Intelligence by Urogynecologic Patients". The goal of this clinical trial is to learn about how Urogynecology patients use Artificial Intelligence (AI) Chatbots like ChatGPT, and how it affects healthcare decision making. The main question\[s\] it aims to answer are: * How does the AI Chatbot affect participants' understanding of diagnoses...
What is the current status of trial NCT06481436?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 125 participants. The study started on 2024-07-22. Estimated completion is 2025-04-01.
What conditions does trial NCT06481436 study?
This clinical trial studies the following conditions: Urinary Incontinence, Lower Urinary Tract Symptoms, Uterovaginal Prolapse.
What interventions are being tested in trial NCT06481436?
The interventions under investigation include: Use of ChatGPT (BEHAVIORAL).
Who is sponsoring clinical trial NCT06481436?
This trial is sponsored by Hartford Hospital, which has 75 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06481436 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Incontinence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06481436's enrollment target sits among peer trials
125 20th of 48 higher than 29 of 48 other Urinary Incontinence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Urinary Incontinence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence
RECRUITING · NA
-
TENS Analgesia During Outpatient Urethral Bulking for Stress Urinary Incontinence.
RECRUITING · NA
-
Adjustable Continence Therapy (ACT) for the Treatment of Female SUI
RECRUITING · NA
-
Improving Overactive Bladder Treatment Access and Adherence
RECRUITING · NA
-
Training for Urinary Leakage Improvement After Pregnancy
RECRUITING · NA
-
Home Biofeedback Therapy for Dyssynergic Defecation, Fecal Incontinence and Urinary Incontinence
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02717039 · 125 participants
Pharmacogenomics of Heparin-Induced Thrombocytopenia
- NCT02763033 · 125 participants · Phase 2
Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients
- NCT02793999 · 125 participants
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
- NCT03003299 · 125 participants · NA
PARTNER 3 Trial - Aortic Valve-in-Valve
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI